Min Li (李旻) received a Bachelor of Science degree from Soochow University, majoring in bioinformatics, under the tutelage of Professor Guang Hu, and is currently working as a data engineer in the team of Dr. Xueli Zhang, PI of Guangdong Provincial People's Hospital (GDPH).
His research interests are mainly in the fields of life sciences & computer science, focusing on data analysis and exploration at the biomolecular level.
Data Engineer, 2023
Guangdong Provincial People's Hospital (GDPH)
BSc in Bioinformatics, 2022
Soochow University
Simple and commonly used programming language
Simpler but memory-intensive programming language
A web framework I’m currently learning
Proficient in software installation and uninstallation
Hobby just getting started
Responsibilities include:
Alzheimer’s disease (AD) is a common neurodegenerative disorder with poorly understood genetic comorbidities. This study identified ten genetic comorbidities and 16 pleiotropic genes linked to AD, providing insights into the molecular basis of AD. Additionally, 50 potential diagnostic biomarkers were discovered, offering new directions for AD diagnosis.
The comorbidity of Alzheimer’s disease (AD) and age-related macular degeneration (AMD) has been established through clinical and genetic studies, with growing interest in identifying shared environmental factors. Leveraging recent advancements in record linkage techniques, a knowledge graph was constructed from literature to include significant risk factors for both conditions. An environment-wide association study (EWAS) using UK Biobank data identified several shared environmental factors across domains like health conditions, biological sample parameters, body index, and attendance availability. A shared etiology landscape for AD and AMD was then generated by integrating these novel findings with existing knowledge.
CBD2 is an updated database for colorectal cancer (CRC) biomarkers, expanding the original collection to 1569 new biomarkers across DNA, RNA, protein, and more, plus data on non-viable biomarkers. It features network analysis for exploring biomarker relationships and supports queries for chemicals and drug combinations, aiding in polypharmacological treatment design. CBD2 is free to use and aims to enhance CRC research and treatment strategies.
Successfully collaborated in a team to replicate a complex research paper, ranking 11th among 131 participating teams.
Achieved Second Prize in the 2023 Guangdong Biomedical Big Data Analysis Community Innovation Competition.
Contact me if you have any interest.